HTN:RDN Episode 4. A Therapy for Today & Tomorrow

HTN:RDN
417 videos
Sharing knowledge of renal denervation (RDN) as a new device-based therapy for control of raised blood pressure
Speakers
Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director,...
Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology. Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.
Professor Felix Mahfoud is an Associate Professor and senior physician of Internal Medicine and Cardiology at...
Professor Felix Mahfoud is an Associate Professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital, and Affiliate/Visiting Professor Harvard-MIT Biomedical Engineering, Institute of Medical Engineering and Science, Cambridge, US. Professor Mahfoud completed training in Cardiology and Interventional Cardiology at the Department for Internal Medicine III, Saarland University Hospital, Germany in 2014. Since 2017, he has served as Vice Chairman of the ‘Working Group on Interventional Hypertension Treatment’ for the European Society of Hypertension, and as a Committee Member of the 2018 Hypertension Guidelines.
Prof. Dr. Weil is Director of the Cardiovascular center at the Sana Clinic in Lübeck. His clinical focus is...
Prof. Dr. Weil is Director of the Cardiovascular center at the Sana Clinic in Lübeck. His clinical focus is interventional therapy of coronary artery disease and arterial hypertension including renal denervation as well chronic heart failure
Dr. Tsioufis, Professor of Cardiology, National and Kapodistrian University of Athens, Director of the Hypertension...
Dr. Tsioufis, Professor of Cardiology, National and Kapodistrian University of Athens, Director of the Hypertension Unit, 1st Cardiology Clinic, Hippokration Hospital, Athens, Greece. Interventional Cardiologist and Hypertension Specialist.
Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the University of the Saarland in...
Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the University of the Saarland in Homburg/Saar in Germany. He has been the principal investigator in several international multicenter studies.
Prof. Peter Sever is Professor of Clinical Pharmacology and Therapeutics at Imperial College London. His research is...
Prof. Peter Sever is Professor of Clinical Pharmacology and Therapeutics at Imperial College London. His research is in the pathophysiology of vascular disease, the evaluation of anti-hypertensive drug therapy and multiple risk factor intervention in hypertensive populations.
Start a conversation